Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition:   InfluenzaIntervention:   Biological: VAX161-01C vaccineSponsor:   VaxInnate CorporationCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition:   InfluenzaIntervention:   Biological: VAX161-01C vaccineSponsors:   VaxInnate Corporation;   VaxInnate CorporationActive, not recruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition:   InfluenzaIntervention:   Biological: VAX161-01C vaccineSponsor:   VaxInnate CorporationCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition:   InfluenzaIntervention:   Biological: VAX161-01C vaccineSponsors:   VaxInnate Corporation;   VaxInnate CorporationActive, not recruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials

Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition:   InfluenzaIntervention:   Biological: VAX161-01C vaccineSponsor:   VaxInnate CorporationCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials